Dr. Mehdi Shishehbor surveys some 2016 papers not to miss
2016 was a highly active year for research in critical limb ischemia (CLI), particularly for CLI expert Mehdi Shishehbor, DO, MPH, PhD, Director of Endovascular Services at Cleveland Clinic.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dr. Shishehbor led teams that generated the following over the past year:
Advertisement
In the two-minute video below, Dr. Shishehbor shares some takeaways from these emerging insights into CLI management, including the necessity of a truly multidisciplinary approach to care.
If you’d like a deeper dive into CLI care, check out this 20-minute video lecture by Dr. Shishehbor on the portion of his JACC expert statement devoted to post-revascularization management after intervention for CLI.
Advertisement
Advertisement
A sampling of outcome and volume data from our Heart & Vascular Institute
Concomitant AF ablation and LAA occlusion strongly endorsed during elective heart surgery
Large retrospective study supports its addition to BAV repair toolbox at expert centers
Young age, solid tumor, high uptake on PET and KRAS mutation signal risk, suggest need for lobectomy
Surprise findings argue for caution about testosterone use in men at risk for fracture
Residual AR related to severe preoperative AR increases risk of progression, need for reoperation
Findings support emphasis on markers of frailty related to, but not dependent on, age
Provides option for patients previously deemed anatomically unsuitable